Kalaris Therapeutics Inc任命Brett Hagen为首席财务官,自2026年4月14日起生效

美股速递
Apr 11

根据提交给美国证券交易委员会(SEC)的文件,生物制药公司Kalaris Therapeutics Inc. (KLRS) 已正式任命Brett Hagen先生担任公司首席财务官(Principal Financial Officer),此项任命将于2026年4月14日正式生效。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10